Patrick Lu
Directeur Général chez SIRNAOMICS LTD.
Fortune : 8 M $ au 30/04/2024
Provenance du réseau au premier degré de Patrick Lu
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Sun Yat-Sen University
117
| College/University | Other Consumer Services | 117 |
| Public Company | Biotechnology | 20 | |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
 Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008.
11
| Subsidiary | Pharmaceuticals: Major | 11 |
Intradigm Corp.
 Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Sirnaomics, Inc.
 Sirnaomics, Inc. Pharmaceuticals: MajorHealth Technology Sirnaomics, Inc. develops novel targeted therapeutics for critical human diseases. It discovers and develops RNAi therapeutics. The firm pursues its proprietary technologies using pluripotent siRNA cocktail design and nanoparticle-enhanced therapeutic delivery to treat critical human diseases. The company was founded by Patrick Y. Lu, George Ji and David M. Evans in 2007 and is headquartered in Gaithersburg, MD.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Guangzhou Natai Biomedical Technology Co., Ltd.
 Guangzhou Natai Biomedical Technology Co., Ltd. BiotechnologyHealth Technology Part of Sirnaomics, Inc., Guangzhou Natai Biomedical Technology Co., Ltd. is a company that manufactures biomedical products. The company is based in Guangzhou, China. Guangzhou Natai Biomedical Technology Co. was acquired by Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. The Chinese company was founded in 2012 by Yang Lu, Jian Jun Ji, Sheng Gao Tang. Sheng Gao Tang has been the CEO since 2012.
2
| Subsidiary | Biotechnology | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Patrick Lu via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BAXTER INTERNATIONAL INC. | Medical Specialties | Corporate Officer/Principal | |
| SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| PARKSON RETAIL GROUP LIMITED | Department Stores | Director of Finance/CFO | |
| Michigan State University | College/University | Doctorate Degree Doctorate Degree | |
| Stanford University | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDING CO., LTD. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| SINOTRANS LIMITED | Air Freight/Couriers | Chairman | |
| CHINA CASTSON 81 FINANCE COMPANY LIMITED | Financial Conglomerates | Director/Board Member | |
Dharmacon, Inc.
 Dharmacon, Inc. Miscellaneous Commercial ServicesCommercial Services Dharmacon, Inc. engages in the research and development for ribonucleic acid synthesis. Its products are gene editing, RNA interference, cDNAs and ORFs, transfection, and viral packaging. The company was founded by Stephen Scaringe in 1995 and is headquartered in Lafayette, CO. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
| RICHLY FIELD CHINA DEVELOPMENT LIMITED | Real Estate Development | Director/Board Member | |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Masters Business Admin Corporate Officer/Principal | |
| SINOTRANS AIR TRANSPORTATION DEVEL. CO | Air Freight/Couriers | Chairman | |
| University of Ottawa | College/University | Doctorate Degree | |
| University of Michigan | College/University | Undergraduate Degree Corporate Officer/Principal | |
| ALAUNOS THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Jinan University | College/University | Graduate Degree Masters Business Admin | |
| China Europe International Business School | College/University | Masters Business Admin Masters Business Admin | |
| South China University of Technology | College/University | Undergraduate Degree Masters Business Admin | |
| Fudan University | College/University | Graduate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| Chinese Academy of Sciences | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree | |
| The Hong Kong University of Science & Technology | College/University | Masters Business Admin Corporate Officer/Principal | |
S*BIO Pte Ltd.
 S*BIO Pte Ltd. Pharmaceuticals: MajorHealth Technology S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and kinases. S*BIO's lead candidate, SB939, entered the clinic in 2007. SB1518, S*BIO's potent and orally-active JAK2 inhibitor, entered the clinic in 2008 and has received orphan drug designation from the U.S. FDA. S*BIO has entered into a development collaboration, and option & license agreement with Onyx Pharmaceuticals, Inc. to develop and commercialize SB1518 and its other novel JAK2 inhibitor, SB1578. S*BIO's SB1317, a novel multikinase inhibitor, is in pre-clinical development and under a worldwide exclusive license with Tragara Pharmaceuticals, Inc. for its development and commercialization. In line with its vision to be a leading fully-integrated oncology-focused biotech company in Asia Pacific, S*BIO has established a state-of-the-art R&D infrastructure, complemented by a strong clinical development team. S*BIO has strong links with a network of medical oncologists in Asia Pacific and its investors include EDB Investments' biomedical sciences subsidiary Bio*One Capital, Aravis Ventures, Novartis Bioventures and other international funds. In 2009, S*BIO received the BioSpectrum Editor's Choice, Emerging BioScience Company of Singapore Award. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Hong Kong Institute of Certified Public Accountants
 Hong Kong Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Hong Kong Institute of Certified Public Accountants operates under the professional accountant’s ordinance and works in the public interest. It offers CPA qualification programme and promulgating financial reporting, auditing and ethical standards in Hong Kong. The company was founded on January 1, 1973 and is headquartered in Hong Kong. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| CRYPTO FLOW TECHNOLOGY LIMITED | Data Processing Services | Chairman Director/Board Member | |
| CHINA ALUMINUM INTERNATIONAL ENGINEERING CORPORATION LIMITED | Engineering & Construction | Chief Executive Officer | |
| KINGOLD JEWELRY, INC. | Other Consumer Specialties | Director/Board Member | |
| PURAPHARM CORPORATION LIMITED | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer | |
| WALVAX BIOTECHNOLOGY CO., LTD. | Biotechnology | Director/Board Member Chairman | |
| Guangzhou Lawyers Association | Corporate Officer/Principal Corporate Officer/Principal | ||
| Adfaith Management Consulting, Inc. | Corporate Officer/Principal | ||
China National Scientific Instruments & Materials Co., Ltd.
 China National Scientific Instruments & Materials Co., Ltd. Medical SpecialtiesHealth Technology China National Scientific Instruments & Materials Co., Ltd. engages in the provision of scientific instruments and medical devices. Its products include CT product series, Contrast injection system, and Intravascular ultrasound system. The company was founded on June 1962 and is headquartered in Beijing, China. | Medical Specialties | Corporate Officer/Principal | |
| Association of Chartered Certified Accountants (Hong Kong) | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | ||
| Guangzhou University of Chinese Medicine | College/University | Doctorate Degree | |
| SHENZHEN REFOND OPTOELECTRONICS CO.,LTD. | Semiconductors | Director/Board Member Director/Board Member | |
| The Chinese Biopharmaceutical Association | President Sales & Marketing | ||
Sinotrans Guangdong Co. Ltd.
 Sinotrans Guangdong Co. Ltd. Air Freight/CouriersTransportation Sinotrans Guangdong Co. Ltd. provides freight forwarding services. The company is based in Guangzhou, China. The Chinese company is a subsidiary of Sinotrans Limited, which is ultimately controlled by the Government of China. | Air Freight/Couriers | Corporate Officer/Principal | |
| Tesco China | Comptroller/Controller/Auditor | ||
| JINGRUI HOLDINGS LIMITED | Real Estate Development | Director/Board Member | |
| Guangdong Shenpeng Law Firm | Corporate Officer/Principal | ||
| Phaeton Investment Consultant Co. Ltd. | Chief Executive Officer | ||
| GLORY HEALTH INDUSTRY LIMITED | Real Estate Development | Corporate Officer/Principal | |
Beijing Glory Xingye Real Estate Co. Ltd.
 Beijing Glory Xingye Real Estate Co. Ltd. Real Estate DevelopmentFinance Part of Glory Health Industry Ltd., Beijing Glory Xingye Real Estate Co. Ltd. is a holding company that provides real estate management services through its subsidiaries. The company is based in Beijing, China. The Chinese company was founded by Zhang Sun Zhang. | Real Estate Development | Corporate Officer/Principal | |
Zhongmei Healthcare Group Ltd.
 Zhongmei Healthcare Group Ltd. Medical/Nursing ServicesHealth Services Zhongmei Healthcare Group Ltd. engages in the Provision of healthcare services and operation of hospital chain. Its business is categorized as comprehensive medical service and hospital management business. The company was founded in 1988 and is headquartered in Beijing, China. | Medical/Nursing Services | Director/Board Member | |
Tianjin Jingxiu Property Investment Co., Ltd.
 Tianjin Jingxiu Property Investment Co., Ltd. Real Estate DevelopmentFinance Tianjin Jingxiu Property Investment Co., Ltd. engages in the development and sale of real estate. Its business scope includes real estate development, property management, and tourism investment. The company was founded on July 24, 2007 and is headquartered in Tianjin, China. | Real Estate Development | Director/Board Member | |
| BEST MART 360 HOLDINGS LIMITED | Food Retail | Chairman | |
China Merchants Hoi Tung Trading Co., Ltd.
 China Merchants Hoi Tung Trading Co., Ltd. Food DistributorsDistribution Services China Merchants Hoi Tung Trading Co., Ltd. is a Chinese company that provides wholesale trading and transportation of food and commodities. It is based in Hong Kong, Hong Kong and ultimately controlled by the Government of China. The company was founded in 1972. | Food Distributors | Director/Board Member |
Statistiques
Internationale
| Chine | 26 |
| Hong Kong | 11 |
| Etats-Unis | 10 |
| Royaume-Uni | 2 |
| Canada | 2 |
Sectorielle
| Consumer Services | 13 |
| Health Technology | 10 |
| Finance | 7 |
| Commercial Services | 4 |
| Transportation | 4 |
Opérationnelle
| Director/Board Member | 306 |
| Corporate Officer/Principal | 169 |
| Independent Dir/Board Member | 93 |
| Undergraduate Degree | 84 |
| Chairman | 61 |
Relations les plus connectées
| Insiders | |
|---|---|
| James Topper | 49 |
| Cheung Hoi Yu | 28 |
| Wei Cheng Diao | 28 |
| Feng Mao Hua | 23 |
| Mohammad Azab | 21 |
| David Mack | 19 |
| Wei Li Hong | 19 |
| Mo Han Shing | 18 |
| Chu Yuan Li | 17 |
| Feng Lian Zhu | 16 |
| Xiao Chang Dai | 15 |
| Chong Liu | 14 |
| Dmitry Samarsky | 13 |
| Jian Xiong Liu | 13 |
| Da Jan Yang | 12 |
- Bourse
- Insiders
- Patrick Lu
- Connexions Sociétés